HDAC inhibitor J22352, Purity ≥98%

Cat. No.: X23-10-ZQ292

HDAC inhibitor J22352, Purity ≥98%

Synonym: 2252395-44-9; J22352; 4-[[2,4-Dioxo-3-(2-phenylethyl)quinazolin-1-yl]methyl]-N-hydroxybenzamide; HDAC inhibitor

  • CAS Number: 2252395-44-9
  • Compound CID: 138377601
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
J22352 induces DNA damage and the inhibition of DNA repair processes.
Molecular Weight
415.44
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
J22352 is used in research to investigate its HDAC inhibitory properties and its potential applications in cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.